Abera Bioscience

6.84 SEK

+3.64 %

Less than 1K followers

ABERA

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+3.64 %
+0.88 %
+9.44 %
+0.59 %
+15.93 %
-13.42 %
+36.80 %
-42.52 %
-38.10 %

Abera Bioscience is a Swedish biotechnology company that develops nasal vaccines based on a proprietary OMV-based platform technology. The company's focus is on nasal vaccines that provide immune responses in both mucosal and systemic areas. Abera develops vaccines against several respiratory infectious diseases, including pneumococci, influenza and pandemic preparedness, with projects in preclinical and planned clinical phases. The company was founded in 2012 and is headquartered in Uppsala.

Read more
Market cap
140.21M SEK
Turnover
9.51K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10/6
2026

General meeting '26

20/8
2026

Interim report Q2'26

17/11
2026

Interim report Q3'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.